Partnering

By fostering deep connections, we accelerate the delivery of transformative medicines and diagnostics — innovating the way we prevent, stop and cure diseases.

We don't just fund innovation, we fuel it. 

We are the only company in the industry with world leading Pharma and Diagnostics under one roof.

This unique synergy allows us to look at the whole patient journey, from early detection to targeted treatment and monitoring.

Today, we manage over 700 active partnerships in Pharma and Diagnostics around the globe. We are actively scouting across a breadth of therapeutic areas and modalities, focusing on those responsible for the majority of current and future global disease burden.

Oncology-Haematology.

Neurology.

Ophthalmology.

Immunology.

And Cardiovascular, Renal and Metabolism.

Together with our partners, we define the best path forward for the asset or molecule, whether through a licensing agreement, a development collaboration or a full acquisition. 

We focus on creating mutual value.

A vision, based on symbiotic partnership.

With our worldwide network, we connect local excellence with global reach.

We draw on a wide range of expertise — from development to commercialisation, but we can’t take on health care's toughest challenges alone.

When we work towards the same goal, we achieve better outcomes for all.

Together, let's create a healthier future by doing now what patients need next.